menu
    • menu
    [{"orgOrder":0,"company":"Ark Biosciences","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CHINA","productType":"Controlled Substance","year":"2026","type":"Inapplicable","leadProduct":"Serdexmethylphenidate Chloride","moa":"DAT | NET","graph1":"Psychiatry\/Psychology","graph2":"Approved FDF","graph3":"Ark Biosciences","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Ark Biosciences \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Ark Biosciences \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Serdexmethylphenidate Chloride

    Menu

    Serdexmethylphenidate Chloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Ark Biosciences

                            China arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Ark Biosciences

                            China arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Serdexmethylphenidate Chloride,Dexmethylphenidate

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Ark Biopharmaceutical Gets China Approval for Aizhida for ADHD Treatment

                            Details : Serdexmethylphenidate Chloride, a controlled substance targeting DAT and NET, shows promise in treating Attention Deficit Hyperactivity Disorder (ADHD).

                            Product Name : Aizhida

                            Product Type : Controlled Substance

                            Upfront Cash : Inapplicable

                            January 08, 2026

                            Lead Product(s) : Serdexmethylphenidate Chloride,Dexmethylphenidate

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.